Matches in Nanopublications for { ?s ?p "[Deregulated signaling via the phosphatidylinositol 3-kinase (PI3K) pathway is common in many types of cancer, but its clinicopathological significance in endometrial cancer remains unclear.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 18 of
18
with 100 items per page.
- assertion description "[Deregulated signaling via the phosphatidylinositol 3-kinase (PI3K) pathway is common in many types of cancer, but its clinicopathological significance in endometrial cancer remains unclear.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Deregulated signaling via the phosphatidylinositol 3-kinase (PI3K) pathway is common in many types of cancer, but its clinicopathological significance in endometrial cancer remains unclear.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Deregulated signaling via the phosphatidylinositol 3-kinase (PI3K) pathway is common in many types of cancer, but its clinicopathological significance in endometrial cancer remains unclear.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Deregulated signaling via the phosphatidylinositol 3-kinase (PI3K) pathway is common in many types of cancer, but its clinicopathological significance in endometrial cancer remains unclear.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Deregulated signaling via the phosphatidylinositol 3-kinase (PI3K) pathway is common in many types of cancer, but its clinicopathological significance in endometrial cancer remains unclear.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Deregulated signaling via the phosphatidylinositol 3-kinase (PI3K) pathway is common in many types of cancer, but its clinicopathological significance in endometrial cancer remains unclear.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Deregulated signaling via the phosphatidylinositol 3-kinase (PI3K) pathway is common in many types of cancer, but its clinicopathological significance in endometrial cancer remains unclear.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Deregulated signaling via the phosphatidylinositol 3-kinase (PI3K) pathway is common in many types of cancer, but its clinicopathological significance in endometrial cancer remains unclear.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Deregulated signaling via the phosphatidylinositol 3-kinase (PI3K) pathway is common in many types of cancer, but its clinicopathological significance in endometrial cancer remains unclear.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP634543.RAV1d6cu5L2hVAsQz0KJZcsWNsTOGEnLRBUxlXMEagBHk130_assertion description "[Deregulated signaling via the phosphatidylinositol 3-kinase (PI3K) pathway is common in many types of cancer, but its clinicopathological significance in endometrial cancer remains unclear.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP634543.RAV1d6cu5L2hVAsQz0KJZcsWNsTOGEnLRBUxlXMEagBHk130_provenance.
- NP634537.RAj91UY1l0xsQdihjJgWzKO9RWMFeZeWA-1JTPkkWqfuM130_assertion description "[Deregulated signaling via the phosphatidylinositol 3-kinase (PI3K) pathway is common in many types of cancer, but its clinicopathological significance in endometrial cancer remains unclear.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP634537.RAj91UY1l0xsQdihjJgWzKO9RWMFeZeWA-1JTPkkWqfuM130_provenance.
- NP634545.RAuvCIBx-alpteEhk3f7dSwFKD60b3Afqadn_BDKL11Xk130_assertion description "[Deregulated signaling via the phosphatidylinositol 3-kinase (PI3K) pathway is common in many types of cancer, but its clinicopathological significance in endometrial cancer remains unclear.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP634545.RAuvCIBx-alpteEhk3f7dSwFKD60b3Afqadn_BDKL11Xk130_provenance.
- NP634552.RAgPAtJVgT0ySDWegtNc0PM0AFmTaz8xDRIG0SDR3HiTw130_assertion description "[Deregulated signaling via the phosphatidylinositol 3-kinase (PI3K) pathway is common in many types of cancer, but its clinicopathological significance in endometrial cancer remains unclear.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP634552.RAgPAtJVgT0ySDWegtNc0PM0AFmTaz8xDRIG0SDR3HiTw130_provenance.
- NP634539.RAPEv7EJqV36r8pbC_7dFILSttnMFLZ00QtamfmMzP11Y130_assertion description "[Deregulated signaling via the phosphatidylinositol 3-kinase (PI3K) pathway is common in many types of cancer, but its clinicopathological significance in endometrial cancer remains unclear.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP634539.RAPEv7EJqV36r8pbC_7dFILSttnMFLZ00QtamfmMzP11Y130_provenance.
- NP634538.RA8VsWbh-3RN5ez9A3fDeT2k83zbDClsX94VU32L5ABmQ130_assertion description "[Deregulated signaling via the phosphatidylinositol 3-kinase (PI3K) pathway is common in many types of cancer, but its clinicopathological significance in endometrial cancer remains unclear.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP634538.RA8VsWbh-3RN5ez9A3fDeT2k83zbDClsX94VU32L5ABmQ130_provenance.
- NP634546.RA_ZlOdjKAF1n0pGKHiPSfHznGJKdu4K8pO-Y-i2MKNjQ130_assertion description "[Deregulated signaling via the phosphatidylinositol 3-kinase (PI3K) pathway is common in many types of cancer, but its clinicopathological significance in endometrial cancer remains unclear.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP634546.RA_ZlOdjKAF1n0pGKHiPSfHznGJKdu4K8pO-Y-i2MKNjQ130_provenance.
- NP634547.RA2LFoBuEXWtLwSpvDecWSxXnPA30QY3TXU24TrxcP4Mk130_assertion description "[Deregulated signaling via the phosphatidylinositol 3-kinase (PI3K) pathway is common in many types of cancer, but its clinicopathological significance in endometrial cancer remains unclear.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP634547.RA2LFoBuEXWtLwSpvDecWSxXnPA30QY3TXU24TrxcP4Mk130_provenance.
- NP634551.RA9CUVCIZT8ueHpPFABr0s3OJN2OU3ZZ4AhAJJxmzXbnU130_assertion description "[Deregulated signaling via the phosphatidylinositol 3-kinase (PI3K) pathway is common in many types of cancer, but its clinicopathological significance in endometrial cancer remains unclear.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP634551.RA9CUVCIZT8ueHpPFABr0s3OJN2OU3ZZ4AhAJJxmzXbnU130_provenance.